NCT06082440 is a EARLY_PHASE1 clinical trial of Human Umbilical Mesenchymal Stem Cells in Osteoarthritis, Knee, sponsored by First Affiliated Hospital of Wannan Medical College.

Who is sponsoring NCT06082440?

NCT06082440 is sponsored by First Affiliated Hospital of Wannan Medical College.

What drugs are being tested in NCT06082440?

Interventions in NCT06082440: Human Umbilical Mesenchymal Stem Cells.

What condition does NCT06082440 study?

NCT06082440 studies Osteoarthritis, Knee.

Is NCT06082440 still recruiting?

NCT06082440 is currently status unknown. Last updated 5 January 2024.

Last reviewed 2024-01-05 · How we verify

NCT06082440

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis

Status unknown EARLY_PHASE1 Last updated 5 January 2024

What this trial tests

EARLY_PHASE1 trial testing Human Umbilical Mesenchymal Stem Cells in Osteoarthritis, Knee in 18 participants. Status unknown.

Timeline

22 November 2023

Primary endpoint
15 August 2025

10 January 2026

Quick facts

Lead sponsor	First Affiliated Hospital of Wannan Medical College
Phase	EARLY_PHASE1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	18
Start date	22 November 2023
Primary completion	15 August 2025
Estimated completion	10 January 2026
Sites	1 location across China

Drugs / interventions tested

Human Umbilical Mesenchymal Stem Cells — full drug profile →

Conditions studied

Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →

Sponsor

First Affiliated Hospital of Wannan Medical College

Who can join

Adults 40 to 60, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells mediated by arthroscopy in patients with knee osteoarthritis. This experiment proposes to enroll 18-22 patients. The experimental drug is human umbilical cord mesenchymal stem cells.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Modular mastery of inflammation: umbilical cord mesenchymal stem cells as a therapeutic frontier.
Yin L, Sun CY, Chen GL, Xiang Z, et al · · 2025 · PMID 41488628 · DOI 10.3389/fimmu.2025.1721947

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting

Other First Affiliated Hospital of Wannan Medical College trials

Trials by the same sponsor.

NCT07501533 — Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke · Phase 2 · not yet recruiting
NCT07127484 — Hemoadsorption for Severe Ischemic Stroke · NA · not yet recruiting
NCT07232082 — Assessing Local Hypothermia and Endovascular Recanalization for Acute Stroke With a Large Core Infarction · NA · not yet recruiting
NCT07027774 — Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter · Phase 4 · not yet recruiting
NCT06990295 — Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06082440 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Wannan Medical College
Last refreshed: 5 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06082440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing